2010 Journal Article The economic implications of treating atherothrombotic disease in australia, from the government perspectiveAdemi, Zanfina, Liew, Danny, Hollingsworth, Bruce, Wolfe, Rory, Steg, Gabriel P., Bhatt, Deepak L. and Reid, Christopher M. (2010). The economic implications of treating atherothrombotic disease in australia, from the government perspective. Clinical Therapeutics, 32 (1), 119-132. doi: 10.1016/j.clinthera.2010.01.009 |
2009 Journal Article Drug treatment and cost of cardiovascular disease in AustraliaAdemi, Zanfina, Liew, Danny, Chew, Derek, Conner, Greg, Shiel, Louise, Nelson, Mark, Soman, Ash, Steg, Gabriel, Bhatt, Deepak L. and Reid, Christopher (2009). Drug treatment and cost of cardiovascular disease in Australia. Cardiovascular Therapeutics, 27 (3), 164-172. doi: 10.1111/j.1755-5922.2009.00090.x |
2009 Journal Article Cost-effectiveness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in AustraliaAl-badriyeh, Daoud, Liew, Danny, Stewart, Kay and Kong, David C.M. (2009). Cost-effectiveness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in Australia. Journal of Antimicrobial Chemotherapy, 63 (1), 197-208. doi: 10.1093/jac/dkn459 |
2006 Journal Article A Model for Undertaking Effectiveness and Cost-Effectiveness Analyses of Primary Preventive Strategies in Cardiovascular Disease.Liew, Danny A., Lim, Stephen S., Bertram, Melanie, McNeil, John J. and Vos, Theo (2006). A Model for Undertaking Effectiveness and Cost-Effectiveness Analyses of Primary Preventive Strategies in Cardiovascular Disease.. European Journal of Cardiovascular Prevention and Rehabilitation, 13 (4), 515-522. doi: 10.1097/01.hjr.0000224488.03221.97 |
2005 Journal Article Epidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged >= 70Nelson, Mark R., Liew, Danny, Bertram, Melanie and Vos, Theo (2005). Epidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged >= 70. British Medical Journal, 330 (7503), 1306-1308A. doi: 10.1136/bmj.38456.676806.8F |
2004 Conference Publication Cost-effectiveness modelling of low-dose aspirin for the primary prevention of cardiovascular diseaseLiew, D., Vos, T., Bertram, M., Lim, S. and McNeil, J. J. (2004). Cost-effectiveness modelling of low-dose aspirin for the primary prevention of cardiovascular disease. 44th Annual Conference on Cardiovascular Disease Epidemiology and Prevention, San Francisco, CA United States, 3-6 March 2004. Philadelphia, PA United States: Lippincott Williams & Wilkins. |
2004 Book Chapter BenzodiazepinesMartin, J., Liew, D. and Johnson, S. (2004). Benzodiazepines. Alcohol and Drug Problems - A Case Studies Workbook. (pp. 132-157) edited by Gary Hulse. Oxford, United Kingdom: Oxford University Press. |
2004 Conference Publication Comparative cost-effectiveness analyses of thiazide diuretics, betablockers, calcium channel blockers and antagonists of the renin angiotensin system for the primary prevention of cardiovascular diseaseLiew, D., Bertram, M., Lim, S., McNeil, J. J. and Vos, T. (2004). Comparative cost-effectiveness analyses of thiazide diuretics, betablockers, calcium channel blockers and antagonists of the renin angiotensin system for the primary prevention of cardiovascular disease. 20th ISH Meeting, Sao Paulo, Brazil, 15-19 Feb 2004. Philadelphia, PA United States: Lippincott Williams & Wilkins. |
2003 Journal Article Eplerenone (Pharmacia)Liew, Danny, Martin, Jennifer and Krum, Henry (2003). Eplerenone (Pharmacia). Current Opinion in Investigational Drugs, 4 (3), 316-322. |
2003 Journal Article Epidemiological modelling (including economic modelling) and its role in preventive drug therapy - In replyLiew, D., McNeil, J. J., Peeters, A., Lim, S. S. and Vos, T. (2003). Epidemiological modelling (including economic modelling) and its role in preventive drug therapy - In reply. Medical Journal of Australia, 178 (4), 188-189. |
2003 Book Chapter Cannabis, hallucinogens and CNS stimulantsJohnson, S., Martin, J. and Liew, D. (2003). Cannabis, hallucinogens and CNS stimulants. Alcohol and drug problems: A case studies workbook. (pp. 61-97) edited by Gary Hulse. Oxford, United Kingdom: Oxford University Press. |
2002 Conference Publication Comparative cost-effectiveness of interventions for the primary prevention of coronary heart diseaseLim, S. S., Vos, T. E., Begg, S., Liew, D., Peeters, A. and McNeil, J. J. (2002). Comparative cost-effectiveness of interventions for the primary prevention of coronary heart disease. American Heart Association Scientific Sessions, Chicago, IL United States, 17-20 November 2002. Philadelphia, PA United States: Lippincott Williams & Wilkins. |
2002 Journal Article Epidemiological modelling (including economic modelling) and its role in preventive drug therapyLiew, D., McNeil, J. J., Peeters, A., Lim, S. S. and Vos, T. (2002). Epidemiological modelling (including economic modelling) and its role in preventive drug therapy. Medical Journal of Australia, 177 (7), 364-367. |
2001 Journal Article Cost-effectiveness of prescribing statins according to Pharmaceutical Benefits Scheme criteriaLim, Stephen S., Vos, Theo, Peeters, Anna, Liew, Danny and McNeil, John J. (2001). Cost-effectiveness of prescribing statins according to Pharmaceutical Benefits Scheme criteria. Medical Journal of Australia, 175 (9), 459-464. doi: 10.5694/j.1326-5377.2001.tb143676.x |
2001 Journal Article A model for predicting the future incidence of coronary heart disease within percentiles of coronary heart disease riskMcNeil, J. J., Peeters, A., Liew, D., Lim, S. and Vos, T. (2001). A model for predicting the future incidence of coronary heart disease within percentiles of coronary heart disease risk. Journal of Cardiovascular Risk, 8 (1), 31-37. doi: 10.1097/00043798-200102000-00005 |